•
Dec 31, 2019

Summit Therapeutics Q4 2019 Earnings Report

Total Revenue
$128K
Previous year: $663K
-80.7%
EPS
-$0.05
Previous year: -$0.08
-37.5%
Gross Profit
-$252K
Previous year: $2.28M
-111.1%
Cash and Equivalents
$63.8M
Previous year: $28.5M
+124.0%
Free Cash Flow
-$6.85M
Previous year: -$22.2M
-69.1%
Total Assets
$96.2M
Previous year: $78.2M
+23.1%

Summit Therapeutics

Summit Therapeutics